128 related articles for article (PubMed ID: 33618568)
1. Synthesis and receptor dependent 4D-QSAR studies of 4,5-dihydro-1,3,4-oxadiazole derivatives targeting cannabinoid receptor.
Hu ZH; Zhao TS; Liu HY; Lin QX; Tu GG; Yang BW
SAR QSAR Environ Res; 2021 Mar; 32(3):175-190. PubMed ID: 33618568
[TBL] [Abstract][Full Text] [Related]
2. Molecular dynamics-guided receptor-dependent 4D-QSAR studies of HDACs inhibitors.
Hu Z; Lin Q; Liu H; Zhao T; Yang B; Tu G
Mol Divers; 2022 Apr; 26(2):757-768. PubMed ID: 33625673
[TBL] [Abstract][Full Text] [Related]
3. 4D-QSAR Studies Using a New Descriptor of the Klopman Index: Antibacterial Activities of Sulfone Derivatives Containing 1, 3, 4-Oxadiazole Moiety Based on MCET Model.
Guzel Y; Aslan E; Turkmenoglu B; Su EM
Curr Comput Aided Drug Des; 2018; 14(3):207-220. PubMed ID: 29756583
[TBL] [Abstract][Full Text] [Related]
4. 4D-QSAR Models Applied to the Study of TGF- β1 Receptor Inhibitors.
Maria de Assis T; Ramalho TC; Ferreira da Cunha EF
Curr Top Med Chem; 2021; 21(13):1157-1166. PubMed ID: 34315368
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of 1,3,4-oxadiazole derivatives.
Jha KK; Samad A; Kumar Y; Shaharyar M; Khosa RL; Jain J; Kumar V; Singh P
Eur J Med Chem; 2010 Nov; 45(11):4963-7. PubMed ID: 20817328
[TBL] [Abstract][Full Text] [Related]
6. The receptor-dependent LQTA-QSAR: application to a set of trypanothione reductase inhibitors.
Barbosa EG; Pasqualoto KF; Ferreira MM
J Comput Aided Mol Des; 2012 Sep; 26(9):1055-65. PubMed ID: 22972559
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antiproliferative and 4D-QSAR studies of thiadiazole derivatives bearing acrylamide moiety as EGFR inhibitors.
Cai BY; Zhao TS; Qin DG; Tu GG
SAR QSAR Environ Res; 2023 Apr; 34(4):341-359. PubMed ID: 37218662
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and 4D-QSAR Studies of Alanine Hydroxamic Acid Derivatives as Aminopeptidase N Inhibitors.
Gao M; Lv Q; Zhang H; Tu G
Med Chem; 2021; 17(6):658-666. PubMed ID: 31880250
[TBL] [Abstract][Full Text] [Related]
9. Studies of cannabinoid-1 receptor antagonists for the treatment of obesity: hologram QSAR model for biarylpyrazolyl oxadiazole ligands.
Ye M; Dawson MI
Bioorg Med Chem Lett; 2009 Jun; 19(12):3310-5. PubMed ID: 19427207
[TBL] [Abstract][Full Text] [Related]
10. 3D-QSAR Studies of 1,2,4-Oxadiazole Derivatives as Sortase A Inhibitors.
Shakour N; Hadizadeh F; Kesharwani P; Sahebkar A
Biomed Res Int; 2021; 2021():6380336. PubMed ID: 34912894
[TBL] [Abstract][Full Text] [Related]
11. Structural insights of dipeptidyl peptidase-IV inhibitors through molecular dynamics-guided receptor-dependent 4D-QSAR studies.
Patil RB; Barbosa EG; Sangshetti JN; Zambre VP; Sawant SD
Mol Divers; 2018 Aug; 22(3):575-583. PubMed ID: 29536226
[TBL] [Abstract][Full Text] [Related]
12. Hierarchical Clustering and Target-Independent QSAR for Antileishmanial Oxazole and Oxadiazole Derivatives.
Teles HR; Ferreira LLG; Valli M; Coelho F; Andricopulo AD
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012163
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, quantitative structure-activity relationship and biological evaluation of 1,3,4-oxadiazole derivatives possessing diphenylamine moiety as potential anticancer agents.
Abdel Rahman DE
Chem Pharm Bull (Tokyo); 2013; 61(2):151-9. PubMed ID: 23370194
[TBL] [Abstract][Full Text] [Related]
14. 4D-LQTA-QSAR and docking study on potent Gram-negative specific LpxC inhibitors: a comparison to CoMFA modeling.
Ghasemi JB; Safavi-Sohi R; Barbosa EG
Mol Divers; 2012 Feb; 16(1):203-13. PubMed ID: 22127637
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, molecular modeling and biological evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazide derivatives as potential anticancer agents.
Zhang F; Wang XL; Shi J; Wang SF; Yin Y; Yang YS; Zhang WM; Zhu HL
Bioorg Med Chem; 2014 Jan; 22(1):468-77. PubMed ID: 24286761
[TBL] [Abstract][Full Text] [Related]
16. 2D- and 3D-QSAR modelling, molecular docking and
Shukla A; Tyagi R; Meena S; Datta D; Srivastava SK; Khan F
J Biomol Struct Dyn; 2020 Jan; 38(1):168-185. PubMed ID: 30686140
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, antiviral activity and three-dimensional quantitative structure-activity relationship study of novel 1,4-pentadien-3-one derivatives containing the 1,3,4-oxadiazole moiety.
Gan X; Hu D; Li P; Wu J; Chen X; Xue W; Song B
Pest Manag Sci; 2016 Mar; 72(3):534-43. PubMed ID: 25847602
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
Sun J; Zhu H; Yang ZM; Zhu HL
Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
[TBL] [Abstract][Full Text] [Related]
19. 4D-QSAR and MIA-QSAR study on the Bruton's tyrosine kinase (Btk) inhibitors.
Ma W; Wang Y; Chu D; Yan H
J Mol Graph Model; 2019 Nov; 92():357-362. PubMed ID: 31450065
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional QSAR analysis and design of new 1,2,4-oxadiazole antibacterials.
Leemans E; Mahasenan KV; Kumarasiri M; Spink E; Ding D; O'Daniel PI; Boudreau MA; Lastochkin E; Testero SA; Yamaguchi T; Lee M; Hesek D; Fisher JF; Chang M; Mobashery S
Bioorg Med Chem Lett; 2016 Feb; 26(3):1011-1015. PubMed ID: 26733473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
